18323000: Drug-induced immune hemolytic anemia, immune complex type (disorder)

SNOMED CT Concept\klinische bevinding (bevinding)\...

\Laboratory test finding (finding)\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\...

\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\Evaluation finding\Measurement finding\Finding of substance level (finding)\Protein level - finding\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Finding of substance level (finding)\Protein level - finding\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Finding of substance level (finding)\Protein level - finding\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Finding of substance level (finding)\Protein level - finding\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Finding of substance level (finding)\Protein level - finding\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\Cytopenia caused by drug (finding)\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\aantal bloedcellen afwijkend (bevinding)\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\Hemoglobin low\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\Hemoglobin low\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\Hemoglobin low\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\Cytopenia caused by drug (finding)\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\bepaling onder referentiebereik\cytopenie (bevinding)\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\bepaling buiten referentiebereik\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Red blood cell count - finding\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Red blood cell count - finding\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Red blood cell count - finding\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Red blood cell count - finding\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\Measurement finding\Red blood cell count - finding\aantal erytrocyten afwijkend\verlaagd aantal erytrocyten\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Evaluation finding\bevinding betreffende hemopoëtisch systeem\hemoglobine buiten referentiebereik (bevinding)\Hemoglobin low\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\bevinding betreffende bloed, lymfatisch systeem en immuunsysteem\bevinding betreffende afbraak van erytrocyten\Hemolysis\hemolytische aandoening (aandoening)\Hemolytic anemia\...

\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\bevinding betreffende functioneren (bevinding)\bevinding betreffende afbraak van erytrocyten\Hemolysis\hemolytische aandoening (aandoening)\Hemolytic anemia\...

\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

\Disease\Disorder of immune function (disorder)\Autoimmune disease\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\Anemia\Anaemia due to substance\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\Anemia\Anaemia due to substance\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\Anemia\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\Anemia\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\Anemia\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Disorder of cellular component of blood (disorder)\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\ziekte van structuur van tractus\hematologische aandoening\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\Anemia due to abnormality extrinsic to the red cell\Antibody-mediated anemia\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\ziekte van structuur van tractus\hematologische aandoening\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\verworven hemolytische anemie\Autoimmune hemolytic anemia (disorder)\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\ziekte van structuur van tractus\hematologische aandoening\aandoening van erytrocyt (aandoening)\hemolytische aandoening (aandoening)\Hemolytic anemia\verworven hemolytische anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type
\Disease\Drug-related disorder\medicatiegeïnduceerde anemie\Hemolytic anemia due to drugs\Drug-induced autoimmune hemolytic anemia\Drug-induced immune hemolytic anemia, immune complex type

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: module van internationale editie (metadata)

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module	Reference Sets
195891013	Drug-induced immune hemolytic anemia, immune complex type	en	synoniem (metadata)	Active	gehele beschrijving niet-hoofdlettergevoelig	module van internationale editie (metadata)	Amerikaans-Engelse taalreferentieset (metadata): voorkeursterm
30938019	Innocent bystander type hemolytic anemia	en	synoniem (metadata)	Active	gehele beschrijving niet-hoofdlettergevoelig	module van internationale editie (metadata)	Amerikaans-Engelse taalreferentieset (metadata): acceptabel
478549014	Innocent bystander type haemolytic anaemia	en	synoniem (metadata)	Active	gehele beschrijving niet-hoofdlettergevoelig	module van internationale editie (metadata)	Brits-Engelse taalreferentieset: acceptabel
478550014	Drug-induced immune haemolytic anaemia, immune complex type	en	synoniem (metadata)	Active	gehele beschrijving niet-hoofdlettergevoelig	module van internationale editie (metadata)	Brits-Engelse taalreferentieset: voorkeursterm
495701000146118	medicatiegeïnduceerde auto-immuunhemolytische anemie van immuuncomplex-type (aandoening)	nl	volledig gespecificeerde naam (metadata)	Active	alleen eerste karakter niet-hoofdlettergevoelig	SNOMED CT Netherlands NRC maintained module (core metadata concept)	Netherlands Dutch language reference set: voorkeursterm
659341000146111	medicatiegeïnduceerde auto-immuunhemolytische anemie van immuuncomplex-type	nl	synoniem (metadata)	Active	alleen eerste karakter niet-hoofdlettergevoelig	SNOMED CT Netherlands NRC maintained module (core metadata concept)	Netherlands Dutch language reference set: voorkeursterm
745727017	Drug-induced immune hemolytic anemia, immune complex type (disorder)	en	volledig gespecificeerde naam (metadata)	Active	gehele beschrijving niet-hoofdlettergevoelig	module van internationale editie (metadata)	Brits-Engelse taalreferentieset: voorkeursterm

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Drug-induced immune hemolytic anemia, immune complex type	Occurrence	Period of life beginning after birth and ending before death (qualifier value)	true	geïnfereerde relatie	existentiële restrictie (metadata)	4
Drug-induced immune hemolytic anemia, immune complex type	locatie van bevinding	Erythrocyte	true	geïnfereerde relatie	existentiële restrictie (metadata)	4
Drug-induced immune hemolytic anemia, immune complex type	Has interpretation	aanwezig	true	geïnfereerde relatie	existentiële restrictie (metadata)	3
Drug-induced immune hemolytic anemia, immune complex type	interpreteert	hemolyse (waarneembare entiteit)	true	geïnfereerde relatie	existentiële restrictie (metadata)	3
Drug-induced immune hemolytic anemia, immune complex type	Pathological process (attribute)	Autoimmune process	true	geïnfereerde relatie	existentiële restrictie (metadata)	7
Drug-induced immune hemolytic anemia, immune complex type	Causative agent	Pharmaceutical / biologic product (product)	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Is a	Drug-induced immune hemolytic anemia	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	locatie van bevinding	Hematopoietic system structure	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Has definitional manifestation	erytropenie (bevinding)	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Has definitional manifestation	Hemolysis	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Has definitional manifestation	bevinding betreffende immuunsysteem	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Causative agent	drug of geneesmiddel (substantie)	true	geïnfereerde relatie	existentiële restrictie (metadata)	5
Drug-induced immune hemolytic anemia, immune complex type	Has interpretation	onder referentiebereik	true	geïnfereerde relatie	existentiële restrictie (metadata)	1
Drug-induced immune hemolytic anemia, immune complex type	Has interpretation	onder referentiebereik	true	geïnfereerde relatie	existentiële restrictie (metadata)	2
Drug-induced immune hemolytic anemia, immune complex type	interpreteert	Red blood cell count	true	geïnfereerde relatie	existentiële restrictie (metadata)	1
Drug-induced immune hemolytic anemia, immune complex type	interpreteert	Measurement of total haemoglobin concentration	true	geïnfereerde relatie	existentiële restrictie (metadata)	2
Drug-induced immune hemolytic anemia, immune complex type	Is a	Drug-induced autoimmune hemolytic anemia	true	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	locatie van bevinding	Erythrocyte	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Causative agent	Drug	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	Causative agent	Antibody	true	geïnfereerde relatie	existentiële restrictie (metadata)	6
Drug-induced immune hemolytic anemia, immune complex type	locatie van bevinding	Structure of immune system (body structure)	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	locatie van bevinding	Hematopoietic system structure	false	geïnfereerde relatie	existentiële restrictie (metadata)
Drug-induced immune hemolytic anemia, immune complex type	interpreteert	afbraak van erytrocyten	false	geïnfereerde relatie	existentiële restrictie (metadata)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start